Lattanzi Roberta, Miele Rossella
Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
Department of Biochemical Sciences "A. Rossi Fanelli", CNR-Institute of Molecular Biology and Pathology, Sapienza University of Rome, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
Life (Basel). 2024 Oct 1;14(10):1254. doi: 10.3390/life14101254.
Prokineticins (PKs) are low molecular weight proteins that exert their effects by binding to two seven-transmembrane G-protein-coupled receptors (prokineticin receptors, PKRs). The prokineticin system is an important player in the development of various diseases. Several polymorphisms that are associated with infertility, neuroendocrine disorders, Hirschsprung's syndrome (HSCR), idiopathic central precocious puberty (CPP) and congenital disorders such as Kallmann syndrome (KS) have been described for both the PKs and PKR genes. The aim of this study is to summarize and describe the impact of PK/PKR polymorphisms on the pathogenesis and outcome of the above diseases, highlighting the PK system as a therapeutic target and diagnostic biomarker in pathological conditions.
促动力蛋白(PKs)是一类低分子量蛋白质,它们通过与两种七跨膜G蛋白偶联受体(促动力蛋白受体,PKRs)结合发挥作用。促动力蛋白系统在多种疾病的发生发展中起着重要作用。已报道PKs和PKR基因存在几种与不孕、神经内分泌疾病、先天性巨结肠(HSCR)、特发性中枢性性早熟(CPP)以及卡尔曼综合征(KS)等先天性疾病相关的多态性。本研究的目的是总结和描述PK/PKR多态性对上述疾病发病机制和结局的影响,强调PK系统作为病理状态下治疗靶点和诊断生物标志物的作用。